Infectious disease diagnostics is the process of identifying presence of foreign antigen/organisms with the help of various diagnostic tools.

Increasing incidence of infectious diseases coupled with technological advancements in disease diagnostic tools are major factors boosting growth of the global Infectious Disease Diagnostics market. Additionally, increasing government initiatives for spreading awareness about infectious diseases and disease diagnostics coupled with increasing investment into development of proper healthcare infrastructure in developing economies are other major factors expected to propel growth of the global market over the forecast period. But, high costs associated with infectious disease diagnostics in developed economies coupled with lack of awareness about infectious diseases in emerging economies are major factors hampering growth of the global market.

A major trend witnessed in the global market is increasing adoption of advanced technologies for disease diagnosis in developing economies. This is another factor expected to support growth of the target market over the forecast period.

The global infectious disease diagnostics market report has been segmented on the basis of test type, technique, condition, end user, and region. On the basis of region, the global infectious disease diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Request Sample Copy of the Report:

The market in North America accounted for highest share in terms of revenue in the global market, and is projected to maintain its dominance over the forecast period. This can be attributed to increasing incidence of infectious diseases and presence of proper healthcare infrastructure in the region. Revenue from the market in Europe accounted for second-highest share, and is closely followed by market in Asia Pacific. The market in Asia Pacific is expected to witness significant growth over the forecast period, and is projected to register a CAGR of X.X%. This is attributed to increasing government initiatives for development of appropriate healthcare infrastructure coupled with growing awareness about infectious diseases and disease diagnosis in emerging economies such as China, Japan, and India.

Prominent players in the global infectious disease diagnostics market include Becton Dickinson & Company, Cepheid Inc., Abbott Laboratories, BioMerieux, Hologic Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Affymetrix, Alere Inc., and DiaSorin.

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: